<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05016180</url>
  </required_header>
  <id_info>
    <org_study_id>IRB2020-YX-083-01</org_study_id>
    <nct_id>NCT05016180</nct_id>
  </id_info>
  <brief_title>Effect of Ultrasound-guided Transversus Abdominis Plane Block After Laparoscopic Bariatric Surgery</brief_title>
  <official_title>Impact of Ultrasound-Guided Transversus Abdominis Plane Block on Postoperative Nausea and Vomiting and Early Outcome After Laparoscopic Bariatric Surgery: a Randomized Double-Blinded Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tianjin Medical University General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tianjin Medical University General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Purpose:&#xD;
&#xD;
      To explore and compare Ultrasound-Guided Transversus Abdominis Plane Block on Postoperative&#xD;
      nausea and vomiting and Early Outcome After Laparoscopic Bariatric Surgery To evaluate and&#xD;
      examine TAPB can reduce the application of intraoperative and postoperative opioids and the&#xD;
      duration of analgesia&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Poor postoperative nausea and vomiting control is a leading factor that hinders the physical&#xD;
      rehabilitation, and causes acute cognitive impairment and chronic pain syndrome. Recently,&#xD;
      the multimodal analgesia strategies to minimise opioid-related side effects are highly&#xD;
      desirable in open surgical procedures. The transversus abdominis plane block is a novel&#xD;
      technique involving injection of local anaesthetic between the internal oblique and the&#xD;
      transversus abdominis muscles of the abdominal wall. Although ropivacaine is most commonly&#xD;
      used for this technique, the analgesic duration remains not dissatisfied. Herein, we will&#xD;
      evaluate the efficacy of ultrasound-guided transversus abdominis plane (USG-TAP) block with&#xD;
      ropivacaine in Laparoscopic Bariatric Surgery&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 25, 2020</start_date>
  <completion_date type="Anticipated">December 25, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 26, 2021</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative nausea and vomiting</measure>
    <time_frame>72 hours after surgery</time_frame>
    <description>Postoperative nausea and vomiting</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cumulative Sufentanyl Consumption</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>Each patient was administered analgesics using a PCA pump containing sufentanil (100μg) in normal saline at a total volume of 100 ml after leaving PACU. This device was set to deliver a basal infusion of 2 ml/h and bolus doses of 0.5 ml with a 15-min lockout period. Sufentanyl cumulative consumption is recorded 24 hours postoperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time of First Postoperative Analgesic Requirement</measure>
    <time_frame>1 hour after surgery</time_frame>
    <description>First postoperative pain (NRS≥4) is initially controlled by titration of sufentanyl</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of Side Effects</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>Occurrence of side effects: nausea, vomiting, dizziness, headache, shivering, pruritus</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Dose of First Postoperative Analgesic Requirement</measure>
    <time_frame>1 hour after surgery</time_frame>
    <description>First postoperative pain (NRS≥4) is initially controlled by titration of sufentanyl.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Nausea and Vomiting</condition>
  <condition>Laparoscopic Bariatric Surgery</condition>
  <arm_group>
    <arm_group_label>Normal Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Before the induction of anesthesia, normal saline is used for bilateral transversus abdominis plane block in a volume of 20 mL of each side</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ropivacaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Before the induction of anesthesia, Ropivacaine is used for bilateral transversus abdominis plane block in a volume of 20 mL of each side</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine</intervention_name>
    <description>Before the induction of anesthesia, ropivacaine is used for bilateral transversus abdominis plane block in a volume of 20 mL of each side</description>
    <arm_group_label>Normal Saline</arm_group_label>
    <arm_group_label>Ropivacaine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Subject is scheduled to undergo Laparoscopic Bariatric Surgery&#xD;
&#xD;
          2. Subject's American Society of Anesthesiologists physical status is I-III.&#xD;
&#xD;
          3. BMI&gt;35kg/m2&#xD;
&#xD;
          4. The subject's parent/legally authorized guardian has given written informed consent to&#xD;
             participate&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Subject has a diagnosis of renal or liver failure.&#xD;
&#xD;
          2. Subject has a diagnosis of mental illness&#xD;
&#xD;
          3. Subject is allergy and contraindication to Ropivacaine.&#xD;
&#xD;
          4. Subject has a history of chronic pain, a history of alcohol or opioid abuse,&#xD;
             pre-existing therapy with opioids, intake of any analgesic drug within 48 hours before&#xD;
             surgery.&#xD;
&#xD;
          5. Subject has any contraindication for the use of patient-controlled analgesia (PCA).&#xD;
&#xD;
          6. Subject is pregnant or breast-feeding.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guolin Wang, MD</last_name>
    <role>Study Director</role>
    <affiliation>Tianjin Medical University General Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zhen Jia, MD</last_name>
    <phone>13002211205</phone>
    <email>1464322162@qq.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Tianjin Medical University General Hospital</name>
      <address>
        <city>Tianjin</city>
        <state>Tianjin</state>
        <zip>300052</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guolin Wang, M.D., Ph. D.</last_name>
      <phone>86-22-60362606</phone>
      <email>wang_guolin@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Guolin Wang, M.D PHD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Zhen Jia</name>
      <address>
        <city>Tianjin</city>
        <state>Tianjin</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jia Zhen, MD</last_name>
      <phone>13002211205</phone>
      <email>1464322162@qq.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>June 30, 2021</study_first_submitted>
  <study_first_submitted_qc>August 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 23, 2021</study_first_posted>
  <last_update_submitted>August 16, 2021</last_update_submitted>
  <last_update_submitted_qc>August 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tianjin Medical University General Hospital</investigator_affiliation>
    <investigator_full_name>Guolin Wang</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nausea</mesh_term>
    <mesh_term>Vomiting</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

